Loading... Please wait... Loading... Please wait...
ESTIMATED
03/14/2024
03/14/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.43 | $1.43 | $1.43 |
| Q2 2024 | 1 | -$1.25 | -$1.25 | -$1.25 |
| Q3 2024 | 0 | $1.31 | $1.31 | $1.31 |
| Q4 2024 | 0 | $0.00 | $0.00 | $0.00 |
Molecular Partners AG last posted its earnings results on Thursday, March 14th, 2024. The company reported $-0.68 earnings per share for the quarter, topping analysts' consensus estimates of $-0.97 by $0.29. The company had revenue of 2.74 M for the quarter and had revenue of 7.04 M for the year. Molecular Partners AG has generated $-2 earnings per share over the last year ($-1.89 diluted earnings per share) and currently has a price-to-earnings ratio of -3.35. Molecular Partners AG has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 26th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/17/2024 | Q1 2024 | -$0.34 | $2.70 M | $2.74 M | 03/14/2024 | Q4 2023 | -$0.97 | -$0.60 | 0.37 | $380,827 | $1.03 M | 09/30/2023 | Q3 2023 | -$0.35 | $2.54 M | 06/30/2023 | Q2 2023 | -$0.49 | $415,000 | 05/12/2023 | Q1 2023 | -$0.47 | $1.65 M | $3.05 M | 03/09/2023 | Q4 2022 | $0.90 | -$0.55 | -1.45 | $4.17 M | $2.69 M | 09/29/2022 | Q3 2022 | -$0.37 | $2.34 M | 08/31/2022 | Q2 2022 | -$0.08 | $11.75 M | 03/31/2022 | Q1 2022 | $4.74 | $165.59 M | $172.78 M | 03/15/2022 | Q4 2021 | -$1.04 | -$0.55 | 0.49 | $14.01 M | $1.78 M | 09/30/2021 | Q3 2021 | -$0.38 | $2.03 M | $3.53 M | 06/30/2021 | Q2 2021 | -$0.53 | $2.02 M | $3.21 M | 03/31/2021 | Q1 2021 | -$0.57 | $3.73 M | $815,000 | 12/31/2020 | Q4 2020 | -$0.74 | $13.73 M | $1.55 M | 09/30/2020 | Q3 2020 | -$0.60 | $8.99 M | $283,000 | 06/29/2020 | Q2 2020 | -$0.63 | $13.61 M | $2.34 M | 03/30/2020 | Q1 2020 | -$0.63 | $13.42 M | $2.34 M | 12/30/2019 | Q4 2019 | -$0.42 | $5.10 M | 09/29/2019 | Q3 2019 | -$0.42 | $5.10 M | 06/29/2019 | Q2 2019 | -$0.42 | $5.10 M |
|---|
A. Molecular Partners AG has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 26th, 2024 based off last year's report dates.
A. In the previous quarter, Molecular Partners AG (NASDAQ:MOLN) reported $-0.68 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.97 by $0.29.
A. The conference call for Molecular Partners AG's latest earnings report can be listened to online.
A. The conference call transcript for Molecular Partners AG's latest earnings report can be read online.
A. Molecular Partners AG (NASDAQ:MOLN) has a recorded annual revenue of $7.04 M.
A. Molecular Partners AG (NASDAQ:MOLN) has a recorded net income of $7.04 M. Molecular Partners AG has generated $-1.89 earnings per share over the last four quarters.
A. Molecular Partners AG (NASDAQ:MOLN) has a price-to-earnings ratio of -3.35 and price/earnings-to-growth ratio is 0.02.
